Details for New Drug Application (NDA): 202328
✉ Email this page to a colleague
The generic ingredient in LEVOFLOXACIN is levofloxacin. There are thirty-one drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the levofloxacin profile page.
Summary for 202328
Tradename: | LEVOFLOXACIN |
Applicant: | Eugia Pharma |
Ingredient: | levofloxacin |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 202328
Suppliers and Packaging for NDA: 202328
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LEVOFLOXACIN | levofloxacin | INJECTABLE;INJECTION | 202328 | ANDA | Eugia US LLC | 55150-156 | 55150-156-20 | 1 VIAL, SINGLE-USE in 1 CARTON (55150-156-20) / 20 mL in 1 VIAL, SINGLE-USE |
LEVOFLOXACIN | levofloxacin | INJECTABLE;INJECTION | 202328 | ANDA | Eugia US LLC | 55150-157 | 55150-157-30 | 1 VIAL, SINGLE-USE in 1 CARTON (55150-157-30) / 30 mL in 1 VIAL, SINGLE-USE |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG/20ML (EQ 25MG/ML) | ||||
Approval Date: | Jan 24, 2013 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 750MG/30ML (EQ 25MG/ML) | ||||
Approval Date: | Jan 24, 2013 | TE: | RLD: | No |
Complete Access Available with Subscription